Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low- versus high-osmolality contrast media.

O Rouvière1, R Ecochard, P Berger

  • 1Department of Vascular and Genitourinary Radiology, Hôital E. Herriot, Lyon, France.

Acta Radiologica (Stockholm, Sweden : 1987)
|October 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simultaneous determination of 8 beta-lactams and linezolid by an ultra-performance liquid chromatography method with UV detection and cross-validation with a commercial immunoassay for the quantification of linezolid.

Talanta·2020
Same author

Candidates to salvage therapy after external-beam radiotherapy of prostate cancer: Predictors of local recurrence volume and metastasis-free survival.

Diagnostic and interventional imaging·2020
Same author

Arterial endofibrosis in endurance athletes: Prospective comparison of the diagnostic accuracy of intra-arterial digital subtraction angiography and computed tomography angiography.

Diagnostic and interventional imaging·2020
Same author

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Computer-aided diagnosis system for characterizing ISUP grade≥2 prostate cancers at multiparametric MRI: A cross-vendor evaluation.

Diagnostic and interventional imaging·2019
Same author

An anatomic study of deep inferior epigastric artery diameters at the origin from external iliac and at the lateral border of rectus abdominis muscle by computed tomographic angiography from autologous breast reconstruction patients.

Annales de chirurgie plastique et esthetique·2019

Low-osmolality contrast media, like iobitridol 350, offer prolonged aortic opacification during CT angiography compared to high-osmolality agents. This extended enhancement is clinically relevant for imaging protocols requiring longer acquisition times.

Area of Science:

  • Radiology and Imaging
  • Medical Contrast Agents
  • Cardiovascular Imaging

Background:

  • Contrast media properties significantly influence imaging outcomes.
  • Abdominal CT angiography requires optimal aortic enhancement for diagnostic accuracy.
  • Understanding pharmacokinetic differences is crucial for selecting appropriate contrast agents.

Purpose of the Study:

  • To compare the pharmacokinetic effects of different contrast media on aortic enhancement.
  • To assess the clinical relevance of these pharmacokinetic differences in abdominal CT angiography.
  • To evaluate low-osmolality versus high-osmolality contrast agents.

Main Methods:

  • A randomized study of 212 patients undergoing abdominal CT angiography.
  • Comparison of iobitridol 300, iobitridol 350 (low-osmolality), and ioxithalamate 350 (high-osmolality).

Related Experiment Videos

  • Standardized CT angiography parameters with a fixed contrast volume and injection rate.
  • Main Results:

    • Iobitridol 350 demonstrated a slower decrease in aortic opacification post-peak enhancement compared to iobitridol 300 and ioxithalamate 350.
    • Iobitridol 350 provided higher mean peak enhancement than iobitridol 300.
    • Time attenuation curves differed between high-osmolality and low-osmolality agents.

    Conclusions:

    • Low-osmolality contrast media, such as iobitridol 350, offer sustained aortic opacification.
    • These agents are recommended for CT angiography protocols with extended acquisition times.
    • Pharmacokinetic differences impact aortic enhancement duration and clinical utility.